Multimodal Imaging for Early Functional Response Assessment of 90Y-/177Lu-DOTATOC Peptide Receptor Targeted Radiotherapy with DW-MRI and 68Ga-DOTATOC-PET/CT

Correlation Between Standardized Uptake Value and Apparent Diffusion Coefficient of Neoplastic Lesions Evaluated With Whole-Body Simultaneous Hybrid PET/MRI

(2013) Rajan Rakheja et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT

(2013) A. Kroiss et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI

(2012) F.L. Giesel et al.   EUROPEAN JOURNAL OF RADIOLOGY

Analysis of the layering pattern of the apparent diffusion coefficient (ADC) for differentiation of radiation necrosis from tumour progression

(2012) Jihoon Cha et al.   EUROPEAN RADIOLOGY

Current knowledge on diagnosis and staging of neuroendocrine tumors

(2011) Kjell Öberg et al.   CANCER AND METASTASIS REVIEWS

Hepatic arterial infusion enhances DOTATOC radiopeptide therapy in patients with neuroendocrine liver metastases

(2011) Clemens Kratochwil et al.   ENDOCRINE-RELATED CANCER

The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors

(2011) Ben Lawrence et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors

(2011) Simon Schimmack et al.   LANGENBECKS ARCHIVES OF SURGERY

Carcinoid Tumors of the Gastrointestinal Tract

(2011) Vishal Ghevariya et al.   SOUTHERN MEDICAL JOURNAL

Surgical Management of Hepatic Neuroendocrine Tumor Metastasis: Results from an International Multi-Institutional Analysis

(2010) Skye C. Mayo et al.   ANNALS OF SURGICAL ONCOLOGY

Intraindividual Comparison of Selective Arterial versus Venous 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors

(2010) C. Kratochwil et al.   CLINICAL CANCER RESEARCH

Predicting and monitoring cancer treatment response with diffusion-weighted MRI

(2010) Harriet C. Thoeny et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors

(2010) D. Campana et al.   JOURNAL OF NUCLEAR MEDICINE

68Ga-DOTATATE PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients with Well-Differentiated Neuroendocrine Tumors

(2010) A. R. Haug et al.   JOURNAL OF NUCLEAR MEDICINE

Transarterial Liver-Directed Therapies of Neuroendocrine Hepatic Metastases

(2010) Javier Nazario et al.   SEMINARS IN ONCOLOGY

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma

(2009) Alejandro Forner et al.   CANCER

Liver metastases of neuroendocrine carcinomas: Interventional treatment via transarterial embolization, chemoembolization and thermal ablation

(2008) Thomas J. Vogl et al.   EUROPEAN JOURNAL OF RADIOLOGY

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

Hepatic Neuroendocrine Metastases: Chemo- or Bland Embolization?

(2008) Susan C. Pitt et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Apparent Diffusion Coefficient: Potential Imaging Biomarker for Prediction and Early Detection of Response to Chemotherapy in Hepatic Metastases

(2008) Yong Cui et al.   RADIOLOGY

Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapy

(2008) Daniel M Patterson et al.   Nature clinical practice. Oncology